The prevalence of pain in patients attending sarcoma outpatient clinics
- PMID: 21647362
- PMCID: PMC3103993
- DOI: 10.1155/2011/813483
The prevalence of pain in patients attending sarcoma outpatient clinics
Abstract
The prevalence of pain in patients with sarcoma is not well documented. We investigated this in outpatients at a tertiary cancer referral centre, assessing the adequacy of pain control and for risk factors leading to higher prevalence and severity of pain. 149 patients were surveyed. Patients with pain within the previous 7 days completed pain assessment tools (BPI, S-LANSS, PMI). 53% of patients had pain within the previous 7 days, and 25% had significant pain. Of those with pain, 63% was inadequately controlled and neuropathic pain was identified in 36%. Age, gender, tumour type, and the type of cancer treatment were not significant predictors of the prevalence or severity of the pain. Based on our results, patients with sarcoma should be actively screened for pain and have regular reviews of their analgesic requirements.
References
-
- van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Annals of Oncology. 2007;18(9):1437–1449. - PubMed
-
- Yates PM, Edwards HE, Nash RE, et al. Barriers to effective cancer pain management: a survey of hospitalized cancer patients in Australia. Journal of Pain and Symptom Management. 2002;23(5):393–405. - PubMed
-
- Dorrepaal KL, Aaronson NK, Van Dam FSAM. Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer. 1989;63(3):593–598. - PubMed
-
- Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996;64(1):107–114. - PubMed
LinkOut - more resources
Full Text Sources
